Revvity Gross Margin 2010-2024 | RVTY
Current and historical gross margin for Revvity (RVTY) over the last 10 years. The current gross profit margin for Revvity as of September 30, 2024 is %.
| Revvity Gross Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Gross Profit | Gross Margin |
| 2024-09-30 | $2.72B | $1.51B | 55.44% |
| 2024-06-30 | $2.71B | $1.50B | 55.26% |
| 2024-03-31 | $2.73B | $1.51B | 55.50% |
| 2023-12-31 | $2.75B | $1.54B | 55.94% |
| 2023-09-30 | $2.80B | $1.59B | 56.94% |
| 2023-06-30 | $2.84B | $1.63B | 57.31% |
| 2023-03-31 | $3.02B | $1.78B | 58.73% |
| 2022-12-31 | $3.31B | $1.99B | 60.08% |
| 2022-09-30 | $3.00B | $2.00B | 66.48% |
| 2022-06-30 | $3.15B | $2.11B | 67.02% |
| 2022-03-31 | $3.48B | $2.24B | 64.45% |
| 2021-12-31 | $3.83B | $2.43B | 63.60% |
| 2021-09-30 | $3.63B | $2.44B | 67.18% |
| 2021-06-30 | $3.74B | $2.44B | 65.44% |
| 2021-03-31 | $3.32B | $2.21B | 66.47% |
| 2020-12-31 | $2.66B | $1.73B | 64.93% |
| 2020-09-30 | $3.23B | $1.68B | 51.96% |
| 2020-06-30 | $2.98B | $1.50B | 50.24% |
| 2020-03-31 | $2.89B | $1.40B | 48.35% |
| 2019-12-31 | $2.88B | $1.40B | 48.40% |
| 2019-09-30 | $2.84B | $1.37B | 48.47% |
| 2019-06-30 | $2.80B | $1.36B | 48.68% |
| 2019-03-31 | $2.78B | $1.36B | 48.74% |
| 2018-12-31 | $2.78B | $1.34B | 48.25% |
| 2018-09-30 | $2.66B | $1.27B | 47.73% |
| 2018-06-30 | $2.54B | $1.21B | 47.50% |
| 2018-03-31 | $2.39B | $1.13B | 47.17% |
| 2017-12-31 | $2.26B | $1.07B | 47.59% |
| 2017-09-30 | $2.18B | $1.04B | 47.85% |
| 2017-06-30 | $2.14B | $1.02B | 47.81% |
| 2017-03-31 | $2.13B | $1.02B | 47.86% |
| 2016-12-31 | $2.12B | $1.02B | 47.99% |
| 2016-09-30 | $2.00B | $0.96B | 48.02% |
| 2016-06-30 | $2.05B | $0.97B | 47.17% |
| 2016-03-31 | $2.08B | $0.97B | 46.48% |
| 2015-12-31 | $2.11B | $0.97B | 45.84% |
| 2015-09-30 | $2.10B | $0.95B | 45.39% |
| 2015-06-30 | $2.07B | $0.94B | 45.27% |
| 2015-03-31 | $2.07B | $0.93B | 45.21% |
| 2014-12-31 | $2.07B | $0.94B | 45.17% |
| 2014-09-30 | $2.22B | $1.00B | 45.22% |
| 2014-06-30 | $2.20B | $0.99B | 45.18% |
| 2014-03-31 | $2.18B | $0.99B | 45.21% |
| 2013-12-31 | $2.16B | $0.98B | 45.25% |
| 2013-09-30 | $2.13B | $0.96B | 45.05% |
| 2013-06-30 | $2.12B | $0.96B | 45.21% |
| 2013-03-31 | $2.10B | $0.96B | 45.48% |
| 2012-12-31 | $2.11B | $0.96B | 45.68% |
| 2012-09-30 | $2.08B | $0.94B | 45.20% |
| 2012-06-30 | $2.03B | $0.91B | 44.89% |
| 2012-03-31 | $1.98B | $0.88B | 44.35% |
| 2011-12-31 | $1.92B | $0.85B | 44.16% |
| 2011-09-30 | $1.85B | $0.82B | 44.20% |
| 2011-06-30 | $1.81B | $0.80B | 44.32% |
| 2011-03-31 | $1.76B | $0.78B | 44.62% |
| 2010-12-31 | $1.70B | $0.76B | 44.54% |
| 2010-09-30 | $1.54B | $0.71B | 45.99% |
| 2010-06-30 | $1.49B | $0.69B | 46.15% |
| 2010-03-31 | $1.51B | $0.69B | 45.59% |
| 2009-12-31 | $1.55B | $0.70B | 45.29% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $15.535B | $2.751B |
| Revvity Inc. provides products, services and solutions to the diagnostics, life sciences and applied services markets worldwide. Its operating segment includes Discovery & Analytical Solutions and Diagnostics. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Revvity Inc., formerly known as PerkinElmer Inc., is based in Waltham, Massachusetts. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $96.890B | 12.02 |
| Cencora (COR) | United States | $46.107B | 17.62 |
| DiDi Global (DIDIY) | China | $23.233B | 0.00 |
| ICON (ICLR) | Ireland | $18.679B | 16.64 |
| Avantor (AVTR) | United States | $15.498B | 23.24 |
| Natera (NTRA) | United States | $15.385B | 0.00 |
| Viatris (VTRS) | United States | $13.858B | 4.22 |
| BioMerieux (BMXMF) | France | $13.601B | 0.00 |
| Solventum (SOLV) | United States | $12.636B | 0.00 |
| CochLear (CHEOY) | Australia | $12.565B | 0.00 |
| Medpace Holdings (MEDP) | United States | $10.202B | 28.74 |
| Charles River Laboratories (CRL) | United States | $9.742B | 18.41 |
| Sonic Healthcare (SKHHY) | Australia | $8.273B | 0.00 |
| HealthEquity (HQY) | United States | $7.792B | 42.29 |
| Doximity (DOCS) | United States | $7.787B | 49.34 |
| Bausch + Lomb (BLCO) | Canada | $6.975B | 32.47 |
| Life Times (LTH) | United States | $4.762B | 31.52 |
| PACS (PACS) | United States | $4.502B | 0.00 |
| Sotera Health (SHC) | United States | $4.367B | 23.36 |
| Organon (OGN) | United States | $4.239B | 4.28 |
| Surgery Partners (SGRY) | United States | $3.778B | 41.86 |
| BrightSpring Health Services (BTSG) | United States | $3.070B | 65.30 |
| Ardent Health Partners (ARDT) | United States | $2.577B | 0.00 |
| Alignment Healthcare (ALHC) | United States | $2.546B | 0.00 |
| Concentras Parent (CON) | United States | $2.480B | 0.00 |
| Premier (PINC) | United States | $2.271B | 11.34 |
| GoodRx Holdings (GDRX) | United States | $2.254B | 84.86 |
| GeneDx Holdings (WGS) | United States | $2.057B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $2.036B | 0.00 |
| Teladoc Health (TDOC) | United States | $1.575B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $1.507B | 7.57 |
| Progyny (PGNY) | United States | $1.425B | 25.06 |
| Establishment Labs Holdings (ESTA) | $1.338B | 0.00 | |
| Pediatrix Medical (MD) | United States | $1.319B | 12.91 |
| CareDx (CDNA) | United States | $1.228B | 0.00 |
| Agilon Health (AGL) | United States | $1.123B | 0.00 |
| Embecta (EMBC) | United States | $0.864B | 5.76 |
| InnovAge Holding (INNV) | United States | $0.822B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.790B | 20.69 |
| SBC Medicals (SBC) | United States | $0.722B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.488B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.483B | 0.00 |
| Enhabit (EHAB) | United States | $0.382B | 33.04 |
| DocGo (DCGO) | United States | $0.355B | 13.35 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.309B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.255B | 0.00 |
| ModivCare (MODV) | United States | $0.232B | 7.37 |
| Beauty Health (SKIN) | United States | $0.211B | 0.00 |
| Biodesix (BDSX) | United States | $0.195B | 0.00 |
| LifeMD (LFMD) | United States | $0.192B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.178B | 0.00 |
| MultiPlan (MPLN) | United States | $0.136B | 0.00 |
| Nutex Health (NUTX) | United States | $0.127B | 0.00 |
| So-Young (SY) | China | $0.092B | 22.35 |
| Harvard Apparatus Regenerative Technology (HRGN) | United States | $0.059B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.057B | 0.00 |
| OncoCyte (OCX) | United States | $0.049B | 0.00 |
| NeueHealth (NEUE) | United States | $0.041B | 1.63 |
| Co-Diagnostics (CODX) | United States | $0.039B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.036B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.027B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.027B | 0.00 |
| Oncology Institute (TOI) | United States | $0.021B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.012B | 0.00 |
| XWELL (XWEL) | United States | $0.009B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.007B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.007B | 0.00 | |
| KindlyMD (KDLY) | United States | $0.005B | 0.00 |
| ISpecimen (ISPC) | United States | $0.004B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.003B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.001B | 0.00 |